Analysis on the herbal administration regularities in the treatment of chest impediment and heart pain by prestigious TCM doctors based on data mining

WANG Weihang; XI Chongcheng; LIU Jintao; ZHAI Shuangqing

doi:10.3969/j.issn.2095-6606.2023.01.024

您当前的位置：

首页 >

文章列表页 >

Analysis on the herbal administration regularities in the treatment of chest impediment and heart pain by prestigious TCM doctors based on data mining

更新时间：2023-02-02

- Analysis on the herbal administration regularities in the treatment of chest impediment and heart pain by prestigious TCM doctors based on data mining
- Modern Chinese Clinical Medicine Vol. 30, Issue 1, Pages: 98-102(2023)
- 作者机构：
  
  1.北京中医药大学中医学院　北京　102401
  2.成都中医药大学基础医学院
- 作者简介：
- 基金信息：
- DOI：10.3969/j.issn.2095-6606.2023.01.024
  CLC： R256.22
- Published：30 January 2023，
  
  Received：08 March 2022，
- 稿件说明：
移动端阅览
WANG Weihang, XI Chongcheng, LIU Jintao, et al. Analysis on the herbal administration regularities in the treatment of chest impediment and heart pain by prestigious TCM doctors based on data mining. [J]. Modern Chinese Clinical Medicine 30(1):98-102(2023)
DOI：

WANG Weihang, XI Chongcheng, LIU Jintao, et al. Analysis on the herbal administration regularities in the treatment of chest impediment and heart pain by prestigious TCM doctors based on data mining. [J]. Modern Chinese Clinical Medicine 30(1):98-102(2023) DOI： 10.3969/j.issn.2095-6606.2023.01.024.

摘要

目的

分析名老中医治疗胸痹心痛的用药规律。

方法

以西医病名为“冠心病”、主诉包含“心痛”“胸痛”作为检索条件，在名老中医传承平台中进行检索，时间范围从建库之日起至2022年2月，通过数据挖掘软件进行频次统计分析、关联规则分析、系统聚类分析和复杂网络分析。

结果

共检索到符合标准的604首处方，涉及6种中医证候，心血瘀阻证最多见。涉及285味中药，出现频次较高的前6味中药依次为丹参、黄芪、当归、枳壳、白术、川芎。中药药性主要为温性、寒性，药味主要为苦味、辛味、甘味。中药归经出现频次较多的有肝经、肺经、脾经。中药功效分析结果显示，补虚药出现频次最多。应用关联规则分析，支持度排名靠前的药对包括“黄芪—丹参”“枳壳—丹参”“白术—丹参”。对频次>30的高频药物进行聚类分析，共得到3类聚类组合。复杂网络分析结果显示，丹参、黄芪、川芎、当归、白术、枳壳为网络的核心节点。

结论

名老中医治疗胸痹心痛以益气活血化瘀为主、化痰通痹止痛为辅。

Abstract

Objective

To analyze the herbal medication regularities of prestigious traditional Chinese medicine (TCM) doctors in treating chest impediment and heart pain.

Methods

With the disease "coronary heart disease" in Western medical terms

and the chief complaints including "cardiodynia" and "chest pain" as the keywords

the search was carried out in Prestigious TCM Doctors Inheritance Platform. The time range was from the date of establishment of the database to February 2022. The frequency statistical analysis

association analysis

hierarchical cluster analysis and complex network analysis were conducted with data mining software.

Results

A total of 604 prescriptions meeting the standard were retrieved

involving 6 TCM patterns

with the most common one being heart blood stasis obstruction. 285 herbal ingredients are involved. The first 6 ones with the highest frequency are Danshen (Radix et Rhizoma Salviae Miltiorrhizae)

Huangqi (Radix Astragali)

Danggui (Radix Angelicae Senensis)

Zhiqiao (Fructus Aurantii)

Baizhu (Rhizoma Atractylodis Macrocephalae)

and Chuanxiong (Rhizoma Chuanxiong). The medicinals are mainly warm and cold in terms of their properties

and the flavors are mainly bitter

acrid and sweet. The most frequently seen meridians entered by the herbs are the liver meridian

the lung meridian and the spleen meridian. As for their functions

the most frequently used are deficiency-supplementing drugs. Association analysis reveals that the drug pairs with the highest support include "Huangqi-Danshen"

"Zhiqiao-Danshen"

and "Baizhu-Danshen" . Cluster analysis was conducted for medicinals with frequency > 30

and three cluster combinations were obtained. The result of the complex network analysis showed that Danshen

Huangqi

Chuanxiong

Danggui

Baizhu

and Zhiqiao were the core nodes.

Conclusion

The treatment of chest impediment and heart pain by the prestigious TCM doctors focuses primarily on boosting qi

invigorating blood and dissolving stasis

supplemented by removing phlegm

diffusing impediment and relieving pain.

关键词

名医经验胸痹心痛数据挖掘

Keywords

famous physician’s experiencechest impediment and heart paindata mining

references

吴勉华.中医内科学[M].北京：中国中医药出版社，2017: 260.

国家卫生计生委合理用药专家委员会，中国药师协会.冠心病合理用药指南(第2版)[J].中国医学前沿杂志(电子版)，2018，10(6): 1-130.

国家药典委员会.中华人民共和国药典：一部[M].北京：中国医药科技出版社，2020.

钟赣生.中药学[M].北京：中国中医药出版社，2016.

国家市场监督管理总局，国家标准化管理委员会.中医临床诊疗术语第2部分：证候：GB/T16751.1－2021[S].北京：中国标准出版社，2021.

张仲景.金匮要略[M].罗希文，译.北京：新世界出版社，2016: 856.

周仲英.中医内科学[M].北京：中国中医药出版社，2007: 135.

万新焕，王瑜亮，周长征，等.丹参化学成分及其药理作用研究进展[J].中草药，2020，51(3): 788-798.

张瑞华，张静文，刘玲，等.黄芪及其有效组分药理作用与临床应用现状[J].陕西中医，2021，42(8): 1138-1141,1146.

陈士铎.精校本草新编[M].北京：人民军医出版社，2013: 50.

马艳春，吴文轩，胡建辉，等.当归的化学成分及药理作用研究进展[J].中医药学报，2022，50(1): 111-114.

崔菊玲.川芎在心血管疾病中的药理及临床应用[J].河南医学研究，2021，30(26): 4992-4994.

罗宝生.当归与川芎药理作用研究进展及对比[J].中国处方药，2016，14(5): 20-22.

郑静，李军.注射用丹参多酚酸治疗冠心病心绞痛的临床研究进展[J].药物评价研究，2020，43(9): 1919-1922.

张瓅方，李梦华，毛秉豫.黄芪、丹参配伍提取物在心肌梗死中的促血管新生作用[J].南阳理工学院学报，2019，11(4): 106-110.

于赛飞，毕然，王亚红.郭维琴益气活血安神法治疗冠心病合并睡眠障碍[J].中医学报，2021，36(12): 2593-2596.

尹嘉.基于数据挖掘的牛天福教授治疗冠心病的用药规律研究[D].太原：山西省中医药研究院，2020.

余臣祖.曹玉山教授学术思想与辨治冠心病的临床经验研究[D].北京：中国中医科学院，2016.

姜丽红，史瑞，魏岩.黄永生教授论治冠心病[J].长春中医药大学学报，2020，36(6): 1127-1129.

张元素.医学启源[M].北京：中国中医药出版社，2007: 108.

阳美平，吴皓，尹莲，等.麦冬皂苷和多糖类成分的研究进展[J].中华中医药学刊，2008，26(10): 2169-2171.

王文燕，陈建光.五味子的药理作用及开发研究[J].北华大学学报(自然科学版)，2007，8(2): 128-133.

伊桐凝，刘会武，张静生.冠脉介入治疗后再狭窄之中医药防治[J].辽宁中医药大学学报，2011，13(6): 142-143.

何昌生，赵海燕.王明福主任医师运用加味生脉饮治疗内科杂病经验[J].光明中医，2019，34(23): 3658-3660.

王荣，白思慧，王露露，等.薤白的化学成分和药理作用研究进展[J].中国野生植物资源，2021，40(10): 73-82.

Views

168

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Exploring the prescription patterns and molecular mechanism of tonifying kidney therapy for insomnia using data mining, network pharmacology, and molecular docking

Exploring professor Lyu Renhe’s medication patterns and mechanisms in managing type 2 diabetes through data mining and network pharmacology analysis

Jiang Liangduo’s experience in managing the pattern of cold and heat in complexity resulting from sanjiao constraint and stagnation

Exploration on the academic thoughts of National TCM Master Prof. Wang Qingguo in the treatment of gynecological diseases based on theory of "shaoyang as the pivot"

Explanation and analysis of Tao Guangzheng’s academic experience in syndrome differentiation and treatment variation of tumors

Related Author

WU Yue

LIU Bowen

CAO Yunsong

SONG Jinhui

CHANG Ze

HAN Zhenyun

ZHOU Jingya

LYU Renhe

Related Institution

Second School of Clinical Medicine, Beijing University of Chinese Medicine

Shenzhen Hospital, Beijing University of Chinese Medicine

Beijing University of Chinese Medicine

Dongzhimen Hospital, Beijing University of Chinese Medicine

Dongfang Hospital, Beijing University of Chinese Medicine

⁰